💊 Medication
ezetimibe
An oral cholesterol-absorption blocker, often added to a statin. Strong evidence it lowers LDL (~18%) and, added to a statin, further cuts cardiovascular events (IMPROVE-IT); it's glucose-neutral and treats the rare disease sitosterolemia. Some proposed benefits (liver fat, cancer, gallstones, Alzheimer's) are more speculative.
5 well-supported · 3 disputed. This shows how settled each sub-question is, not whether ezetimibe is "good." Direction lives in each claim below.
The 9 claims about ezetimibe
Each keeps its own verdict — we never average them away.
Does ezetimibe treat the rare disease sitosterolemia?
Strong support Yes, it blocks the plant-cholesterol over-absorption that defines the disease and is the treatment of choice.
ezetimibe does not increase diabetes risk
Strong support
Does ezetimibe meaningfully lower LDL cholesterol?
Strong support Yes — ezetimibe lowers LDL by roughly 15-20% as monotherapy and adds a similar increment on top of a statin, a modest but reliable and well-documented effect.
rosuvastatin + ezetimibe combination decreases cardiovascular disease
Strong support
Does the cholesterol drug ezetimibe prevent gallstones?
Insufficient 🐭 Non-human evidence Not in people. Animal studies hint at it, but two large genetic studies that mimic the drug's action found no protection against gallstones in humans. A speculative possible side-benefit, not an established one.
ezetimibe decreases cardiovascular disease
Leans support
ezetimibe decreases liver fat
Leans against
ezetimibe decreases Alzheimer's disease
Refuted
ezetimibe decreases cancer risk
Refuted
Educational only, not medical advice. Hub descriptions are curated for honesty; see the methodology.